Al-Anbagi Usamah, Abusriwil Hatem M, Palol Azeez, Emsalem Mohamed, Abdelhamid Alaa, Nashwan Abdulqadir J
Internal Medicine, Hazm Mebaireek General Hospital/Hamad Medical Corporation, Doha, QAT.
Medical Education, Hazm Mebaireek General Hospital/Hamad Medical Corporation, Doha, QAT.
Cureus. 2025 Jul 7;17(7):e87462. doi: 10.7759/cureus.87462. eCollection 2025 Jul.
Antiphospholipid syndrome (APS) is a rare autoimmune condition associated with a heightened risk of blood clots in arteries and veins due to the presence of specific antibodies. IgA nephropathy (IgAN), a kidney disorder involving immune complex deposition, is another immune-mediated disease. The coexistence of APS and IgAN is highly uncommon. We describe a young adult male with biopsy-confirmed kidney involvement who developed a significant clot in the lower limb. Despite appropriate treatment, the clot progressed, leading to complications in the lungs. Further investigation revealed laboratory findings consistent with APS. The patient underwent advanced interventions including clot removal and vascular procedures, followed by long-term treatment to prevent further clotting. This study emphasizes the clinical complexity when these two immune-mediated conditions overlap and underscores the importance of early detection and collaborative care in managing such rare and serious presentations.
抗磷脂综合征(APS)是一种罕见的自身免疫性疾病,由于存在特定抗体,导致动脉和静脉血栓形成风险增加。IgA肾病(IgAN)是一种涉及免疫复合物沉积的肾脏疾病,是另一种免疫介导的疾病。APS和IgAN同时存在极为罕见。我们描述了一名经活检证实有肾脏受累的年轻成年男性,其下肢出现了一个大的血栓。尽管进行了适当治疗,但血栓仍在进展,导致肺部出现并发症。进一步检查发现实验室检查结果与APS相符。患者接受了包括血栓清除和血管手术在内的高级干预措施,随后进行长期治疗以预防进一步血栓形成。本研究强调了这两种免疫介导疾病重叠时的临床复杂性,并强调了早期检测和协作护理在管理此类罕见且严重病症中的重要性。